Nicox S.A. (ALCOX.PA)

EUR 0.23

(-0.43%)

Total Debt Summary of Nicox S.A.

Nicox S.A.'s latest annual total debt in 2023 was 25.15 Million EUR , down -0.57% from previous year.
Nicox S.A.'s latest quarterly total debt in 2023 FY was 25.15 Million EUR , down -0.57% from previous quarter.
Nicox S.A. reported annual total debt of 25.29 Million EUR in 2022, up 17.63% from previous year.
Nicox S.A. reported annual total debt of 21.5 Million EUR in 2021, up 12.74% from previous year.
Nicox S.A. reported quarterly total debt of 25.15 Million EUR for 2023 Q4, down 0.0% from previous quarter.
Nicox S.A. reported quarterly total debt of 21.15 Million EUR for 2023 Q2, up 3.78% from previous quarter.

Annual Total Debt Chart of Nicox S.A. (2023 - 2019)

Historical Annual Total Debt of Nicox S.A. (2023 - 2019)

Year	Total Debt	Total Debt Growth
2023	25.15 Million EUR	-0.57%
2022	25.29 Million EUR	17.63%
2021	21.5 Million EUR	12.74%
2020	19.07 Million EUR	0.0%
2019	- EUR	0.0%

Year	Total Debt	Total Debt Growth
2023 FY	25.15 Million EUR	-0.57%
2023 Q4	25.15 Million EUR	0.0%
2023 Q2	21.15 Million EUR	3.78%
2023 Q1	20.38 Million EUR	-19.42%
2022 Q4	25.29 Million EUR	0.0%

Peer Total Debt Comparison of Nicox S.A.

Name	Total Debt	Total Debt Difference
European Medical Solutions	18.13 Million EUR	-38.729%
FERMENTALG	15.35 Million EUR	-63.821%
argenx SE	18.1 Million EUR	-38.926%
BioSenic S.A.	28.16 Million EUR	10.681%
Celyad Oncology SA	902 Thousand EUR	-2688.581%
Hyloris Pharmaceuticals SA	5.29 Million EUR	-375.123%
Onward Medical N.V.	16.87 Million EUR	-49.064%
Oxurion NV	12.33 Million EUR	-103.932%
PHAXIAM Therapeutics S.A.	10.19 Million EUR	-146.622%
Financière de Tubize SA	79.2 Million EUR	68.241%
UCB SA	3.03 Billion EUR	99.172%